update on phase ii study of hyper-cvad with ponatinib in patients with ph all
Published 1 year ago • 417 plays • Length 5:41Download video MP4
Download video MP3
Similar videos
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:44
insights into the phase ii tidal study
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
1:31:54
ihn virtual webinar on pathophysiology of transfusion reactions
-
43:14
treatment options for hcm
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
0:50
insights into the phase ii window-2 trial
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
1:35
update on phase i study of plamotamab in r/r nhl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies